|
| Tia A Tummino | Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF) |
| Tia A Tummino | |
| Tia A Tummino | Quantitative Biosciences Institute (QBI) |
| Tia A Tummino | Graduate Program in Pharmaceutical Sciences and Pharmacogenomics |
| Veronica V Rezelj | Institut Pasteur, CNRS UMR 3569 |
| Benoit Fischer | Novartis Institutes for BioMedical Research, Preclinical Safety |
| Audrey Fischer | Novartis Institutes for BioMedical Research, Preclinical Safety |
| Matthew J O'Meara | University of Michigan ann arbor |
| Blandine Monel | Institut Pasteur, CNRS UMR 3569 |
| Thomas Vallet | Institut Pasteur, CNRS UMR 3569 |
| Kris M White | Icahn School of Medicine at Mount Sinai |
| Kris M White | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Ziyang Zhang | Quantitative Biosciences Institute (QBI) |
| Ziyang Zhang | Howard Hughes Medical Institute |
| Ziyang Zhang | |
| Ziyang Zhang | |
| Assaf Alon | Blavatnik Institute, Harvard Medical School |
| Heiko S Schadt | Novartis Institutes for BioMedical Research, Preclinical Safety |
| Henry R O'Donnell | Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF) |
| Jiankun Lyu | Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF) |
| Jiankun Lyu | |
| Jiankun Lyu | Quantitative Biosciences Institute (QBI) |
| Romel Rosales | Icahn School of Medicine at Mount Sinai |
| Romel Rosales | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Briana L McGovern | Icahn School of Medicine at Mount Sinai |
| Briana L McGovern | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Raveen Rathnasinghe | Icahn School of Medicine at Mount Sinai |
| Raveen Rathnasinghe | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Raveen Rathnasinghe | Icahn School of Medicine at Mount Sinai |
| Sonia Jangra | Icahn School of Medicine at Mount Sinai |
| Sonia Jangra | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Michael Schotsaert | Icahn School of Medicine at Mount Sinai |
| Michael Schotsaert | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Jean-Rene Galarneau | Novartis Institutes for BioMedical Research, Preclinical Safety |
| Nevan J Krogan (CM4AI) | Quantitative Biosciences Institute (QBI) |
| Nevan J Krogan (CM4AI) | |
| Nevan J Krogan (CM4AI) | |
| Nevan J Krogan (CM4AI) | Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes |
| Laszlo Urban | Novartis Institutes for BioMedical Research, Preclinical Safety |
| Kevan M Shokat | Quantitative Biosciences Institute (QBI) |
| Kevan M Shokat | |
| Kevan M Shokat | |
| Kevan M Shokat | Howard Hughes Medical Institute |
| Andrew C Kruse | Blavatnik Institute, Harvard Medical School |
| Adolfo Garc??a-Sastre | Icahn School of Medicine at Mount Sinai |
| Adolfo Garc??a-Sastre | Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai |
| Adolfo Garc??a-Sastre | Icahn School of Medicine at Mount Sinai |
| Adolfo Garc??a-Sastre | Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai |
| Olivier Schwartz | Institut Pasteur, CNRS UMR 3569 |
| Marco Vignuzzi | Institut Pasteur, CNRS UMR 3569, France. francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com. |